1366641-92-0

Upstream product

• 1186304-33-5 C₃₉H₄₂O₈ 
• 6399-81-1 triphenylphosphine hydrobromide 
• 137898-13-6 2-trifluoromethylsulphonyloxy-3-methoxybenzaldehyde 
• 17100-64-0 (4-bromo-3-methoxyphenyl)methanol 
• 17100-63-9 methyl 4-bromo-3-methoxybenzoate 
• 17100-70-8 2-(4-bromo-3-methoxy-benzyloxy)-tetrahydro-pyran 
• 101553-99-5 C₁₈H₁₉BrO₄ 
• 603-35-0 triphenylphosphine 
• 1186304-42-6 C₃₉H₄₄O₈ 
• 1186304-19-7 4-[5-(1,3-dioxan-2-yl)-2-methoxyphenoxy]benzaldehyde 
• 1186304-34-6 C₃₁H₃₀O₆ 
• 1186304-32-4 2',6-dimethoxy-4'-[(tetrahydro-2H-pyran-2-yloxy)methyl]biphenyl-2-carbaldehyde 
• 1186304-18-6 5-(1,3-dioxan-2-yl)-2-methoxyphenol 
• 1186304-20-0 {4-[5-([1,3]-dioxan-2-yl)-2-methoxyphenoxy]benzyl}triphenylphosphonium bromide 

Relevant academic research and scientific papers

Design, synthesis and biological evaluation of nitrogen-containing macrocyclic bisbibenzyl derivatives as potent anticancer agents by targeting the lysosome

A series of novel nitrogen-containing macrocyclic bisbibenzyl derivatives was designed, synthesized, and evaluated for antiproliferative activity against three anthropic cancer cell lines. Among these novel molecules, the tri-O-alkylated compound 18a disp

Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents

Based on the core skeleton of the total synthesized bisbibenzyl marchantin C, riccardin D and plagiochin E, a series of brominated and aminomethylated derivatives of above three bisbibenzyls have been synthesized and their cytotoxic activity against KB, M